{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Company Interviews","title":"Impact Minerals (ASX:IPT) - Advancing Scoping Study With 10x Throughput Breakthrough in Hand","html":"","width":"100%","height":180,"duration":1687,"description":"Interview with Dr. Mike Jones, MD of Impact Minerals Ltd.\nOur previous interview: https://www.cruxinvestor.com/posts/impact-minerals-asxipt-pitch-perfect-october-2025-8328\nRecording date: 8th June 2026\nImpact Minerals Limited (ASX:IPT) is undergoing a deliberate and material transformation. What began as a junior mining explorer is becoming, under the direction of Managing Director Dr. Mike Jones, a specialty chemicals and material science company with a credible path to producing high-purity alumina which is  a critical input for battery separators, artificial sapphire, advanced ceramics, and semiconductor components.\nThe company's commercial strategy rests on two interconnected assets. The first is a 50% stake in Alluminous, which holds a patented solvent extraction process for producing HPA from widely available chemical feedstock. That intellectual property is now protected across the United States, Canada, and Southeast Asia, jurisdictions that management views as the primary commercialisation markets. The second is the Lake Hope clay project in Western Australia, where a Pre-Feasibility Study has been completed and work toward a Definitive Feasibility Study is underway.\nWhat has sharpened investor attention recently is a process engineering breakthrough at the Alluminous pilot plant. By modifying the orientation of impellers in the solvent extraction stage, the team achieved up to ten times the originally designed throughput. Dr. Jones has stated that this discovery could allow the company to reach production capacity comparable to its listed peers for under AU$10 million in capital — against the AU$200 million-plus spent by those peers to reach similar output levels. The scoping study for a 2,000-tonne-per-annum commercial plant is expected to provide independent cost validation shortly, making it one of the most significant near-term catalysts for the stock.\nThe competitive context is instructive. Alpha HPA carries a market capitalisation of approximately...","thumbnail_url":"https://img.transistorcdn.com/1wv-MFlQAgnm-ca64e5kK4984dZB0os8-HJdRVsI74M/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzEzNTcyLzE2MjM5/NTQyMDctYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}